The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia ; volume:9 ; number:2 ; day:15 ; month:1 ; year:2019 ; pages:1-4 ; date:2.2019
Blood cancer journal ; 9, Heft 2 (15.1.2019), 1-4, 2.2019
- Creator
-
Moharram, Sausan A.
Shah, Kinjal
Khanum, Fatima
Rönnstrand, Lars
Kazi, Julhash U.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-018-0169-1
- URN
-
urn:nbn:de:101:1-2019020111221896029958
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moharram, Sausan A.
- Shah, Kinjal
- Khanum, Fatima
- Rönnstrand, Lars
- Kazi, Julhash U.
- SpringerLink (Online service)
Other Objects (12)
Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
ALK
ALK
"ALK
ALK
ALK
ALK
ALK
ALK
ALK
Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
ALK
ALK
"ALK
ALK
ALK
ALK
ALK
ALK
ALK
Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
ALK
ALK
"ALK
ALK
ALK
ALK
ALK
ALK